Your session is about to expire
← Back to Search
Stem Cell and Growth Factor Therapy for Osteoarthritis (GARM-MSK-ALD Trial)
GARM-MSK-ALD Trial Summary
This trial is studying a new way to treat osteoarthritis by using a person's own stem cells and growth factors.
GARM-MSK-ALD Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowGARM-MSK-ALD Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.GARM-MSK-ALD Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am not currently dealing with drug addiction or in rehab.I have enough healthy tissue for donation.I do not have any infections that could make treatment risky for me.You have had serious brain injuries in the past.I can follow treatment and post-treatment instructions.I have not used high dose steroids or received corticosteroids in the last 6 months.I am currently receiving treatment for active cancer.I have documented arthritis or tissue degeneration in my knee, hip, shoulder, Achilles tendon, Sacroiliac Joint, wrist/hand, foot/ankle, or have Plantar Fasciitis.I have enough healthy tissue for donation.You have a condition that makes it difficult for you to understand and tolerate the procedures and follow-up requirements of the study.
- Group 1: tSVF + PRP Arm1
- Group 2: tSVF + PRP + cSVF Arm 2
- Group 3: Normal Saline IV + cSVF Arm 3
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are my characteristics compatible with the criteria to participate in this experiment?
"For this osteoarthritis research project, 100 individuals aged 18 to 90 are being sought. Candidates must be free of systemic disorders which could jeopardise their safety; have ample donor tissue around their blood vessels and extracellular matrixes; and possess the maturity necessary to abide by treatment plans as well as fulfil post-treatment tracking requirements."
Is this clinical trial actively enrolling participants?
"Confirmed, this medical study is still seeking participants. It has been listed on clinicaltrials.gov since January 10th 2020 and was last revised in April of 2022."
What outcomes is this medical research attempting to demonstrate?
"The primary aim of this research is to evaluate the effect of Participant with Complications over Baseline, 6 months and 1 year. Secondary goals encompass assessing Foot and Ankle Disability Index (FADI) for changes in disability caused by pain and function; Knee Injury & Osteoarthritis Outcome Score (KOOS) determining knee health through gauging levels of pain from osteoarthritis; as well as Foot & Ankle Ability Measure (FAAM), which monitors shifts in discomfort, range-of-motion, and performance."
Is there an age limit to participation in this experiment?
"This research protocol is open to any individuals aged 18 and below 90."
How many people have enrolled in this medical experiment?
"Yes, the pertinent data hosted on clinicaltrials.gov confirms that recruitment for this medical study is ongoing. The information was initially posted on October 1st 2020 and most recently updated on April 7th 2022. This experiment necessitates the enrolment of 100 individuals at two distinct sites."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger